CHINA PHARMA HOLDINGS, INC. Convertible Preferred Dividends, Net of Tax
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Convertible Preferred Dividends, Net of Tax of $4.55 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Earnings Per Share
us-gaap:ConvertiblePreferredDividendsNetOfTax · last filed 2022-11-14
- CHINA PHARMA HOLDINGS, INC. convertible preferred dividends, net of tax for the quarter ending 2022-09-30 was -$200.00K.
- CHINA PHARMA HOLDINGS, INC. convertible preferred dividends, net of tax for the quarter ending 2022-06-30 was -$200.00K.
- CHINA PHARMA HOLDINGS, INC. convertible preferred dividends, net of tax for the quarter ending 2022-03-31 was $4.95M.
| Period end | Convertible Preferred Dividends, Net of Tax 3 month | Convertible Preferred Dividends, Net of Tax 6 month | Convertible Preferred Dividends, Net of Tax 9 month |
|---|---|---|---|
| 2022-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$400.00K derived: sum of 2 quarters · filed 2022-11-14 | $4.55M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $4.75M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.95M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |